Bank of America’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $45.1M | Sell |
|
|||||
|
2025
Q2 | $51.3M | Buy |
|
|||||
|
2025
Q1 | $43.9M | Buy |
|
|||||
|
2024
Q4 | $32.7M | Buy |
|
|||||
|
2024
Q3 | $13M | Buy |
|
|||||
|
2024
Q2 | $7.12M | Buy |
|
|||||
|
2024
Q1 | $6.51M | Sell |
|
|||||
|
2023
Q4 | $12.6M | Buy |
|
|||||
|
2023
Q3 | $6.86M | Sell |
|
|||||
|
2023
Q2 | $8.9M | Sell |
|
|||||
|
2023
Q1 | $16.3M | Buy |
|
|||||
|
2022
Q4 | $17M | Buy |
|
|||||
|
2022
Q3 | $6.11M | Buy |
|
|||||
|
2022
Q2 | $842K | Sell |
|
|||||
|
2022
Q1 | $2.1M | Sell |
|
|||||
|
2021
Q4 | $2.34M | Buy |
|
|||||
|
2021
Q3 | $672K | Sell |
|
|||||
|
2021
Q2 | $1.06M | Sell |
|
|||||
|
2021
Q1 | $942K | Sell |
|
|||||
|
2020
Q4 | $806K | Sell |
|
|||||
|
2020
Q3 | $810K | Buy |
|
|||||
|
2020
Q2 | $590K | Buy |
|
|||||
|
2020
Q1 | $480K | Sell |
|
|||||
|
2019
Q4 | $540K | Sell |
|
|||||
|
2019
Q3 | $937K | Sell |
|
|||||
|
2019
Q2 | $812K | Buy |
|
|||||
|
2019
Q1 | $125K | Sell |
|
|||||
|
2018
Q4 | $81K | Buy |
|
|||||
|
2018
Q3 | $45K | Buy |
|
|||||
|
2018
Q2 | $17K | Sell |
|
|||||
|
2018
Q1 | $105K | Buy |
|
|||||
|
2017
Q4 | $71K | Buy |
|
|||||
|
2017
Q3 | $18K | Buy |
|
|||||
|
2017
Q2 | $4K | Hold |
|
|||||
|
2017
Q1 | $3K | Sell |
|
|||||
|
2016
Q4 | $2K | Buy |
|
|||||
|
2016
Q3 | $2K | Sell |
|
|||||
|
2016
Q2 | $18K | Buy |
|
|||||
|
2016
Q1 | $2K | Sell |
|
|||||
|
2015
Q4 | $39K | Sell |
|
|||||
|
2015
Q3 | $178K | Sell |
|
|||||
|
2015
Q2 | $396K | Buy |
|
|||||
|
2015
Q1 | $278K | Sell |
|
|||||
|
2014
Q4 | $253K | Buy |
|
|||||
|
2014
Q3 | $260K | Buy |
|
|||||
|
2014
Q2 | $191K | Buy |
|
|||||
|
2014
Q1 | $40K | Buy |
|
|||||
|
2013
Q4 | $27K | Sell |
|
|||||
|
2013
Q3 | $67K | Sell |
|
|||||
|
2013
Q2 | $20K | Buy |
|